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ABSTRACT 
Matthew S. Bryington, D.M.D.: Molecular Assessment of Endosseous Implant Adherent 
Cellular Phenotypes in Man 
(Under the direction of Lyndon F. Cooper, D.D.S., Ph.D.) 
 
 This investigation considered the role of implant surface roughness on activation 
of osteoblastic differentiation of uncommitted mesenchymal stem cells in humans.   The 
aim of this study was to examine the gene expression profiles from adherent cells on 
moderately roughened TiO2 grit-blasted (micron-scale topography) and hydrofluoric acid 
modified TiO2 grit-blasted (nano-scale topography) implants. Sixty cpTitanium implants 
were placed and allowed to integrate for 24 hours, 72 hours, and one week in 10 
systemically healthy patients.  These implants were retrieved and biochemical analyzed 
by RT-PCR for markers of osteoblastic differentiation.  A complex array of gene changes 
representative of osteogenesis was observed at both implant surfaces.  Compared to 
implants with micron-scale topography, nano-scale topography implants supported 
greater expression of RUNX-2(1.6 vs. 2.6-fold, p=0.18), Osterix (1.8 vs. 3.9-fold, 
p=0.04), BSP(2.7 vs. 4.6-fold, p=0.11) and OCN(1.6 vs. 3.2-fold, p=0.06)  mRNAs 
indicating greater osteogenesis at 7 days in vivo. Further investigations using this model 
may elucidate important difference among subsets of patients who experience implant 
failure. 
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CHAPTER 1 
INTRODUCTION 
 Endosseous implants are of widespread importance in the medical and dental 
profession.  It has been widely demonstrated that implant surface plays a major role in 
mediating the bone-to-implant interface (Albrektsson and Johansson 2001).  The 
importance of osseointegration in clinical dentistry has been accepted as the basis of 
implant success (Albrektsson 2001).  The high implant success rates achieved in the 
dense bone present in the parasymphaseal mandible and have not been achieved in other 
more clinically difficult situations (Shalabi, Gortemaker et al. 2006).  Also, for a subset 
of patients such as smokers (Bain 1996) and diabetics (Fiorellini, Chen et al. 2000), there 
are anecdotal reports of difficulty achieving high implant success rates.  These failures, 
while not specifically determined, have been attributed to failure of bone formation 
leading to osseointegration.  Several factors have been associated as being involved with 
failure of osseointegration including, anatomic, local biologic, and systemic factors 
(Shalabi, Gortemaker et al. 2006; Mendonca, Mendonca et al. 2008).  Control of these 
complex factors has been a central focus of implant research for several decades 
(Mendonca, Mendonca et al. 2008).  These findings have lead to a large investment in 
dental implant surface technologies as a means to promote and achieve greater 
osseointegration (Mendonca, Mendonca et al. 2008).      
In 1990 AstraTech Dental released the TiOblast
TM
 implant.  The TiOblast
TM
 
surface was a commercially pure titanium implant that has been sprayed with titanium
 2 
 
dioxide (TiO2) (Hansson and Norton 1997).  This produced a moderately roughened grit 
blasted surface with micron level surface topography(Hansson and Norton 1999).  The 
importance of micron topographic surfaces was demonstrated in a study by Buser and 
colleges where he compared a moderately roughened surface to a polished machined 
surface and a hydroxyapatite rough surface (Buser, Schenk et al. 1991).  He observed that 
the moderately roughened surface was capable of faster and greater bone accrual as 
compared to the positive and negative controls.  This has lead to the use of micron 
topographic implants in the clinical setting and has provided the TiOblast
TM
 implant with 
one of the longest clinical follow-up periods in the dental literature (Albrektsson and 
Wennerberg 2004).   
The TiOblast
TM
 surface was the precursor to the AstraTech Dental Osseospeed
TM
 
(released 2004) surface which was a further advancement of the TiOblast
TM
 moderately 
roughened surface.  It was produced by chemically treating the TiO2 grit blasted 
TiOblast
TM
 implant with hydrofluoric acid (HF) which results in nanometer-sized 
topographical features as well as incorporating fluoride ions onto the TiO2 surface.  The 
use of nanotopographic surfaces demonstrates an entrance into nanotechnology which 
was defined by the National Aeronautics and Space Administration as, “the creation of 
functional materials, devices and systems through control of matter on the nanometer 
length scale (1-100 nm), and exploitation of novel phenomena and properties (physical, 
chemical, and biological) at that length scale.”(Mendonca, Mendonca et al. 2008)  The 
application of nanotopographic surface features on dental implants typically involves a 
two dimensional association of the features occurring both across and away from the 
mean surface of the implant.   These features can be developed in two arrangements 
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either isotropic (organized manner) or anisotropic (unorganized manner).  Due to the 
technical complexities inherent in implant design most nanofeatures in implant dentistry 
are anisotropic (Mendonca, Mendonca et al. 2008). 
Several in vitro and in vivo studies have implicated that nanotopographic implant 
features can enhance (1) the physical interaction of the implant with bone, (2) the rate of 
bone formation at the implant surface, and (3) increases the implant survival rate in 
various situations (Mendonca, Mendonca et al. 2008).  It is believed that these effects can 
be attributed to complex changes not just at or on the implant surface topography but the 
surface chemistry as well.  It is often considered a complication of nanoscale 
manipulation that the surface will acquire unique chemical properties that are not inherent 
in the bulk material (Mendonca, Mendonca et al. 2008).  Some theorize that imparting 
nanotopography to dental implants may allow for biomimicry of the cellular environment 
(Palin, Lui et al. 2005).   An example of this being the epithelial basement membrane 
which contain pores that are approximately 70-100 nm (Brody, Anilkumar et al. 2006); 
similarly it has been suggested that surface bone roughness is approximately 32 nm.  
These examples lend credence that cellular structures may contain nanotopographic 
elements. 
Cells are able to detect and react to nanostructures.  It has been found that cells 
react to these nanotopographic features by both a direct and indirect manner (Mendonca, 
Mendonca et al. 2008).  Indirect interactions with cells are mediated by increased surface 
protein adherence (Mendonca, Mendonca et al. 2008).  Direct interactions are mediated 
by integrin receptors which interact with the implant surface to control adhesion, 
spreading, and motility (Berry, Dalby et al. 2006; Mendonca, Mendonca et al. 2008).   
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The molecular phenotype of cells adherent to endosseous implants can be 
measured after explantation.  Early retrieval of endosseous dental implants has permitted 
the morphologic, biochemical and molecular assessment of the adherent cellular 
phenotype (Sul, Johansson et al. 2005).  The advent of real-time Polymerase Chain 
Reaction (RT-PCR) allows for the measurement of gene expression at the mRNA level 
by permitting assessments from only a few cells and enables a comprehensive evaluation 
of osteoinductive and bone-specific gene expression events in cells adherent to explanted 
endosseous dental implants (Guo, Padilla et al. 2007).    
Early explanation of experimental implants from humans is possible. A human 
model of osseointegration using healthy volunteers has provided access to histological 
data following up to 6 months of healing followed by explantation and histological 
assessment (Ivanoff, Widmark et al. 2003).  This model involved trephination of the 
implant and surrounding bone.  Rocci and Colleagues also performed a histological 
comparative study examining bone formation around TiOblast (micron topography) 
implants and Osseospeed (nanotopography) implants (Rocci, Rocci et al. 2008).  At eight 
and twelve weeks they found that bone accrued faster and with greater volume around 
nanotopography implants in humans.   
In the current project, the molecular phenotype of cells adherent to endosseous 
implants retrieved from human volunteers were evaluated by a) isolation of mRNA from 
the adherent cells, b) synthesis of cDNA from the isolated mRNA by reverse 
transcription, and c) measurement of the steady state level of targeted, relevant 
osteoinductive and bone-specific mRNAs by RT-PCR.   
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Adherent cell molecular phenotypes can be quantitatively compared among 
surfaces by RT-PCR(Livak and Schmittgen 2001) (Guo, Padilla et al. 2007).  The 
molecular assessments performed by RT-PCR can be highly quantitative.  The data is 
also normalized to a set of so-called housekeeping genes that are thought to be expressed 
at relatively constant levels throughout the diverse physiological changes of the cell’s 
lifetime.  Thus, expression of data by statistical methods permits a kinetic and 
comparative analysis of gene expression among the two test surfaces.   
 This study involved explantation of endosseous dental implants following one to 
seven days of healing by reverse threading of the implants.  It is possible to evaluate 
molecular changes in the phenotype of adherent cells that occur during the important first 
days of the osseointegration process.  Experimental implants were surgically placed in 
healthy volunteers and explanted after one, three, and seven days for quantitative, kinetic- 
analysis of gene expression of seven different osteoinductive and bone-specific genes in 
the implant adherent cells.  This will provide the first molecular assessment of the early 
wound healing and osseointegration process in man and may provide important new 
molecular information regarding improvements in dental implant surface characteristics 
to promote or support the process of osteoinduction.   
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CHAPTER 2 
MATERIALS AND METHODS 
A total of 10 systemically healthy individuals were enrolled in an approved 
clinical study by the Institutional Committee on Human Subjects Research at the 
University Of North Carolina School Of Dentistry (IRB Protocol #08-0941).  Subjects 
were required to be between the ages of 18 and 70, be able to provide informed consent, 
and had sufficient interradicular space to allow for implant placement without damaging 
sensitive anatomical structures.  Subjects were excluded if they presented with a major 
systemic disease (HTN, diabetes, CVD, etc.), pregnant, or taking medications that 
affected bone healing.  Candidate subjects that met the selection criteria of the study were 
provided with a clinical examination and panoramic radiologic analysis.  A signed 
informed consent approved by the institutional review board was obtained for each 
patient. 
Implant sites were selected to provide implant placement of the implants into 
interradicular sites that would not impinge on teeth, nerves, or blood vessels.  Six 
experimentally designed implants were placed into three prepared surgical sites with each 
site receiving a microtopography and nanotopography implant.  Implants were fabricated 
by AstraTech Dental (AstraTech, MoIndal, Sweden) from Type IV commercially pure 
titanium and were 2.2 mm wide by 5.0 mm long (Fig 1).  Implants were surface treated to 
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impart either a TiO2 grit blasted micro roughened surface (AstraTech, TiOblast 
proprietary surface) used as a control or a hydrofluoric acid TiO2 grit blasted 
nanotopographic experimental surface (AstraTech, OsseoSpeed proprietary surface).  
Surface treatment of implants was verified by SEM analysis performed internally by 
AstraTech.  Figure 2 shows an SEM analysis of an OsseoSpeed 2.2 x 5.0 mm implant. 
All subjects were given presurgical medications of 1 g amoxicillin, 800 mg 
ibuprofen, and chlorohexidine rinse for 30 seconds.  Adequate surgical sites were 
selected and three full thickness incisions were made (one incision per experimental site), 
tissues were elevated by a mucoperiosteal elevator under local anesthesia with lidocaine 
2% with epinephrine (1:100,000) or mepivacaine 4%.  Two osteotomies were prepared 
per surgical site using a single 2.0mm twist osteotomy drill, prepared to 5 mm depth 
utilizing sterile saline irrigation (Fig 3).  The control implants (TiOblast) were placed in 
the most superior osteotomy site by a self-tapping procedure using hand torque wrenches. 
Experimental implants (HF modified TiO2 grit blasted implants) were placed in the most 
inferior osteotomy site.  Bone quality and quantity assessments were made at time of 
surgery to insure primary stability at time of placement (Fig 4).  Each site was sutured to 
allow primary closure with 4.O chromic gut suture.  For each time point: 24 hours, 72 
hours, and one week, one of the three surgical sites was re-exposed and the implants were 
removed by reverse threading utilizing an Astra prosthetic driver (Fig 5).  Explantation 
site selection was based on clinical signs of tissue healing to allow for the least trauma to 
gingival tissues. 
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Explanted implants were immediately rinsed in neutral phosphate buffered saline 
(PBS) to remove blood products and non-adherent cells.  Implants were then placed in 
Trizol Reagent (Invitrogen, Carlsbad, CA), cell lysates were snap frozen in dry ice, and 
stored at -80
o
C until further use.  Total RNA was isolated utilizing the Trizol protocol 
and precipitated with ethanol according to manufacturer’s instructions.  Total RNA was 
quantified by Nanodrop spectrophotometer (Thermo Scientific, Wilmington, DE). 
For each total RNA sample, cDNA was generated utilizing Superscript
TM
 III 
reverse transcriptase (Invitrogen, Carlsbad, CA) in a 20 μL reaction.  Equal volumes of 
cDNA were used to program a RT-PCR array (SA Biosciences, Frederick, MD) encoded 
for mRNAs of Osterix, RUNX-2, BSP, BMP6, ALP, OCN, OPN, and GAPDH.  
Reactions were performed using a TaqMan Universal PCR Master Mix with an ABI 7000 
RT thermocycler for SYBR Green absorbance.  Normalizing to GAPDH abundance, 
relative mRNA abundance was determined by the 2
-ΔΔCt 
method and reported as fold 
induction (Livak and Schmittgen 2001; Guo, Padilla et al. 2007). 
STATISTICAL ANALYSIS 
 Descriptive statistics were calculated utilizing Microsoft Excel.  SABiosciences 
RT
2
 Profiler
TM
 PCR Array Data Analysis software was utilized to analyze RT-PCR data, 
and generate results by the 2
-ΔΔCt method
.
  Tukey’s test was used to evaluate the difference 
between mRNA levels on each implant surface per time point to the 95% confidence 
level (p<0.05). 
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CHAPTER 3 
RESULTS 
 Markers of osteoblastic differentiation were detected to be expressed in all 
implant samples at each time interval.   Following implantation, a complex interaction of 
molecular interactions occurred at the implant surface. 
 Fold induction, the ratio of experimental activity compared to the control activity, 
was calculated for all samples by normalization to GAPDH expression.  Graph 1 
illustrates measurement of mRNA levels at day seven.  All samples were found to have 
greater gene expression around the nanotopography HF modified TiO2 grit blasted 
surface (Osseospeed).  To determine the effects of nanotopographic surfaces on 
osteogenesis the osteogenic transcription factors Osterix and RUNX-2 were evaluated 
(Graph 2).  At seven days, the mRNA levels of Osterix demonstrated a significant 
increase (p=0.04) on nanotopographic surfaces (3.94-fold) as compared to the 
microtopographic surfaces (TiOblast) (1.84-fold).  RUNX-2 demonstrated a similar 
preference for nanotopographic surfaces (micron 1.61 vs. nano 2.65-fold) but failed to 
reach significance (p=0.18).  These findings are in agreement with previous in vitro and 
in vivo animal studies that demonstrated greater mRNA levels around nanotopographic 
implants (Mendonca, Mendonca et al. ; Guo, Padilla et al. 2007; Mendonca, Mendonca et 
al. 2009; Mendonca, Mendonca et al. 2009). 
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 For several genes the gene expression on microtopographic surfaces exceeded the 
corresponding expression at 1 week at the 72 hour time point.  As can be seen on Graph
 3 and Graph 4, Osteocalcin (OCN), BMP6, BSP, and Osterix (OSX) all followed a 
pattern of greater expression of mRNAs on TiO2 grit blasted surfaces at 72 hours as 
compared to gene expression at 1 week.  Interestingly, gene expression on 
microroughend surfaces actually exceeded expression on nanotopographic surfaces for 
OCN, BMP6, and OSX.  However, statistical analysis revealed that none of these 
differences achieve statistical significance.  
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CHAPTER 4 
DISCUSSION 
 The examination of wound healing around dental implants has been of scientific 
interest for several decades.  Numerous in vitro and histological studies have suggested 
that implant surface characteristics play an essential role in mitigating this interaction 
(Albrektsson and Wennerberg 2004; Albrektsson and Wennerberg 2004).  This study 
represents the first in vivo molecular biological analysis in humans demonstrating that 
implant surface does have a role in affecting the gene expression profiles of adherent 
cells on cpTitanium implants. 
 In the present study ten systemically healthy patients were enrolled from the 
patient population at the University of North Carolina at Chapel Hill.  These patients 
received six surgically placed 2.2 X 5mm experimental micro implants that were 
imparted with either a TiO2 grit blasted microtopographic surface or a HF modified TiO2 
grit blasted nanotopographic surface.  Both of these surfaces correspond to the 
proprietary AstraTech Dental (MoIndal, AB) TiOblast and Osseospeed surfaces 
respectively.  Implants were removed by reverse threading at one day, three days, and 
one week post implantation. 
 In this study all markers of osteoblastic gene expression showed increased 
expression on nanotopgraphic surfaces at 1 week as compared to micron topographic 
surfaces.  Previous in vitro studies have shown that osteoblastic gene expression on TiO2 
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and TiO2/HF surfaces occurs sooner than on polished machine surface (Guo, Padilla et al. 
2007).  This study supports these findings by demonstrating osteoblastic gene expression 
at 3 days post insertion.   
As previously stated, mRNA levels for Osteocalcin (OCN), BMP6, BSP, and 
Osterix (OSX) were greater on microroughened surfaces at 72 hours as compared to 1 
week.  There are several possibilities that could cause this pattern of mRNA expression 
including a response to pro-inflammatory markers, statistical error as result of small 
sample size, or an otherwise unknown biological process.  Additional research would be 
required to elucidate a possible mechanism for this phenomenon. 
 The examination of osteoblastic transcription factors has been utilized in several 
studies to elucidate the role implant surfaces may play on osteogenesis.  In this study we 
examined the key osteogenic transcription factors of RUNX2 and Osterix.  Previous 
knockout mice studies have demonstrated that both of these transcription factors are 
required for the development of bone (Nakashima, Zhou et al. 2002).  RUNX2 functions 
as a major osteoblastic transcription factor considered necessary to initiate differentiation 
of undifferentiated human mesenchymal stem cells into osteoblast precursor cells 
(Komori).   Osterix functions downstream of RUNX2 and is considered the master 
osteogenic transcription factor, it is considered to be the essential factor determining if a 
cell will become an osteoblast or a chondroblast (Nakashima, Zhou et al. 2002).   In the 
present study, both RUNX2 (1.6- vs. 2.6-fold, p=0.0) and Osterix (1.8 vs. 3.9-fold, 
p=0.04) were found to be expressed at greater levels on HF modified nanotopgraphic 
surfaces.  The observation that Osterix is expressed at significantly greater (p=0.04) 
levels on nanotopgraphic surfaces lends itself  to the concept that HF modified TiO2 grit 
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blasted nanotopographic surfaces are better capable of supporting osteoinduction of 
adherent cells. 
 This study lends support to previous studies that examined TiO2/HF surfaces 
effects on MC3T3-E1 cells.  The MC3T3-E1 cell is a murine calvarial osteoprogenitor 
cell line that is considered to be a committed osteoprogenitor.  It is routinely utilized to 
study osteogenesis through several important ostrogenic signaling pathways (ex., BMP, 
RUNX-2, PTH, Wnt and Dlx-5).  That study found that TiO2/HF nanotopographic 
implants demonstrated greater expression of both the RUNX-2 and Osterix transcription 
factors at 3 and 7 days suggesting that the HF acid modified surface could better support 
osteoinduction. (Guo, Padilla et al. 2007) 
 When compared to cultured osteoblastic cell studies, the induction of osteogenic 
markers on nanotopgraphic implant surfaces in humans may further indicate a specific 
influence on early populations of undifferentiated cells.  The presence of greater mRNA 
levels of Osterix can lead to the conclusion that greater osteoinduction occurs in cells 
adherent to nanotopographic implants.  This helps to explain earlier histological analysis 
where bone formation around nanotopographic implants was demonstrated to occur much 
quicker as compared to TiO2 microtopographic implants (Rocci, Rocci et al. 2008).  
A limitation in this study is that the variation in gene expression among 
individuals is not known. While it is possible to derive statistically meaningful data from 
as few as 4 or 5 inbred strains of rodents, it may require as many as 10 – 12 human 
volunteers for robust statistical analysis (Boyle, Rosengren et al. 2003).  Another 
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limitation is that we are only analyzing cells adhered to the implant surface which may 
represent only a fraction of cells participating in wound healing and osseointegration.       
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CHAPTER 5 
CONCLUSIONS
 In conclusion this study represents the first biomolecular analysis of early implant 
healing in humans.  Previous studies have only focused on histological analysis.  This 
study also demonstrates that it is possible to analyze molecular interactions occurring 
around dental implants in human subjects and that nanoscale modification of titanium 
surfaces do in fact alter behavior of adherent cells.  Indeed, Osterix transcription factor 
was significantly expressed at higher levels at 1 week with nanotopographic implants 
than microtopographic implants.  This could be indicative of greater osteoblastic 
differentiation around implants which explains the more rapid bone formation observed 
by histology.  This study also indicates that enough total RNA can be obtained for future 
research interests such as gene array analysis of adherent implant cells and molecular 
analysis of implant failure in specific subsets of patients that have greater incidence of 
failure.   
 This study shows that implant surface topography does play a role in mediating 
the function of osteoblasts which could indicate greater or faster osseointegration.  By 
demonstrating that nanotopographic surface modifications do interact with peri-implant 
cells, it helps to validate the need for implant surface research and could lead to surface 
technologies that promote even greater osseointegration.  Utilizing this method it would 
also be possible to evaluate other commercially available implant surfaces and determine 
if the observed surface interactions are exclusive to a hydrofluoric acid modified 
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nanotopographic surface or if other implant surfaces can mediate these interactions.  This 
technique also lends itself to possibly determining the molecular basis of implant failure 
by examining cell to implant interactions in subsets of patients that routinely have poor 
implant success (e.g. smokers and diabetics).  By examining this subset in comparison to 
healthy individuals it may elucidate the cause for implant failure and allow for the design 
of implants that can overcome this.  
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CHAPTER 6 
TABLES AND FIGURES 
 
Figure 1 
The AstraTech Dental 2.2 x 5.0 mm experimental implant.  Six of these implants were 
placed in each of ten systemically healthy individuals.  This implants surfaces were either 
treated by TiO2 grit blasting to impart a micron scale topography surface or TiO2 grit 
blasting followed by modification with hydrofluoric acid to impart a nano scale 
topography surface. 
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Figure 2 
SEM Photograph of experimental 2.2 x 5.0mm HF modified TiO2 grit blasted implant at 
500x (left) and 5000x (right) magnification.  Note the inclusion of pits and grooves 
present on the surface of the implant at the 5000x magnification.  The anisotropic nature 
of the nanotopographic surface is easily discernible  
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  TiOblast 72 hr Osseospeed 72 hr TiOblast 1 wk Osseospeed 1 wk 
ALP -1.0371 -1.3172 -1.9003 -1.2027 
OCN 2.5937 2.5535 1.576 3.1629 
BMP6 2.256 1.858 1.1388 1.8198 
BSP 4.1411 4.1518 2.6735 4.6468 
RUNX2 1.8564 2.4773 1.6105 2.6482 
OPN 4.9717 3.0684 7.1046 7.9931 
OSX 4.7899 3.4313 1.8404 3.9449 
GAPDH 1 1 1 1 
 
Table 1 
The table of fold induction for all genes at 72 hours and 1 week post implantation.  Fold 
induction is calculated by using TiOblast 24hour samples as a control.  GAPDH is 
utilized as a control gene to allow for standardization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
 
Figure 3 
 Prepared osteotomies.  Three individual implant surgical sites were prepared in each 
patient.  Each site would contain two osteotomies prepared to a 5 mm depth.  This 
approach was utilized so that explantation surgeries would not disrupt healing around 
other implant sites. 
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Figure 4 
Experimental implants in place.  Implants were placed to insure greatest intimate contact 
with the osteotomy site.  The micron topography control implant was placed in the most 
superior osteotomy site.  Implants were allowed to heal for twenty-four hours, seventy-
two hours, and one week post insertion.   
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Figure 5 
Explantation surgery.  Implants were removed by reverse threading.  This allowed the 
analysis of only adherent cells.  The trephination of these implants may have removed 
additional cells not involved with the peri-implant healing as well as increase study 
subject morbidity.  Explanted implants were immediately rinsed in neutral Phosphate 
Buffered Saline (PBS) to remove blood products and loosely adherent cells.  Implants 
were then placed in Trizol Reagent to lyses cells in preparation of biochemical analysis. 
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Graph 1 
The graph of fold induction at one week.  Real-time PCR measurement of mRNA levels 
of the adherent cells to cpTitanium implants.  At day seven, mRNA expression levels 
were measured, nanotopography implants showed greater gene expression of all gene 
markers but these differences were not statistically significant.  GAPDH was used as the 
control gene.   
 
 
 
 
 
 
24 
 
 
Graph 2 
The graph of fold induction at one week for transcription factors.  To elucidate how 
nanotopography surfaces may affect osteogenesis we analyzed the key transcription 
factors of RUNX2 and OSX.  Greater expression of transcription factors were seen on 
nanotopographic surfaces, with OSX expression being significantly greater expression 
(p=0.04) as compared to microtopography surfaces.   
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Graph 3 
Fold regulation as a function of time.  OSX has greater expression on micron topography 
implants at 72 hours which precipitously fell at the 1 week mark.  At one week 
nanotopography implants had greater expression of transcription factors than 
microtopography implants.  There are several possibilities for this pattern including a 
response to pro-inflammatory markers, statistical error a result of small sample size, or an 
otherwise unknown biological process.  Additional research would be required to 
elucidate a possible mechanism for this analysis.   
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Graph 4 
The graph of mRNA expression at 72 hr and 1 week.  Note that mRNA levels are greater 
for OCN, BMP6, and OSX at the 72 hour time point than at the 1 week point.  For BMP6 
and OSX, micron topography implants actually exceed mRNA levels of nanotopography 
implants at the 1 week mark.  All micron topography mRNA levels are lower at the 1 
week mark.  
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